Preventing Cardiovascular Outcome in Patients with Renal Impairment: Is There a Role for Lipid-Lowering Therapy?

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.5, Iss.4, 2005-01, pp. : 255-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyperlipidaemia in Paediatric Patients: The Role of Lipid-Lowering Therapy in Clinical Practice

By Wierzbicki Anthony S.

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Consider lipid-lowering therapy for patients with diabetes and hyperlipidaemia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Lipid-lowering Drug Therapy in Elderly Patients

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 877-893

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-Lowering Therapy in Patients with Average Cholesterol and High Cardiovascular Risk, Insights from the Heart Protection Study

By Salam Amar

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 387-389

Springer Publishing Company

Access to resources Recommend Favorite

Lipid-lowering therapy in diabetes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite